Abbott Laboratories vs. MoonLake Immunotherapeutics Class A Ordinary Shares
ABT
Abbott Laboratories
$102.51 +1.99%
VS MLTXMoonLake Immunotherapeutics Class A Ordinary Shares
$12.34 +15.87%
Abbott Laboratories and MoonLake Immunotherapeutics Class A Ordinary Shares are evenly matched on the factors we track — the better pick depends on what you're optimizing for.
Size & Scale
| ABT | MLTX | |
|---|---|---|
| Market Cap | $173.92 billion | $906.39 million |
ABT leads on 1 of 1 size & scale factors.
Dividend
| ABT | MLTX | |
|---|---|---|
| Dividend Yield | 2.46% | — |
ABT and MLTX split the dividend factors evenly.
Risk & Sentiment
| ABT | MLTX | |
|---|---|---|
| Short Interest | 0.57% | 0.05% |
MLTX leads on 1 of 1 risk & sentiment factors.
Dig deeper: ABT overview, ABT financials, MLTX overview, MLTX financials.
Comparisons use delayed, cached fundamental data and cover only the factors shown. For informational purposes only — not investment advice.